A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers (Q83433369)
Jump to navigation
Jump to search
scientific article published on 17 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers |
scientific article published on 17 February 2011 |
Statements
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers (English)
E E Vokes
D J Haraf
T Seiwert
J K Salama
E A Blair
M E Witt
R Williams
R Kunnavakkam
17 February 2011